Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1886

1.

Intraoperative ventilator settings and their association with postoperative pulmonary complications in neurosurgical patients: post-hoc analysis of LAS VEGAS study.

Robba C, Hemmes SNT, Serpa Neto A, Bluth T, Canet J, Hiesmayr M, Hollmann MW, Mills GH, Vidal Melo MF, Putensen C, Jaber S, Schmid W, Severgnini P, Wrigge H, Battaglini D, Ball L, Gama de Abreu M, Schultz MJ, Pelosi P; FERS for the LAS VEGAS investigators; PROtective VEntilation Network and the Clinical Trial Network of the European Society of Anaesthesiology.

BMC Anesthesiol. 2020 Apr 2;20(1):73. doi: 10.1186/s12871-020-00988-x.

2.

Genetic alterations in the PI3K/AKT pathway and baseline AKT activity define AKT inhibitor sensitivity in breast cancer patient-derived xenografts.

Gris-Oliver A, Palafox M, Monserrat L, Brasó-Maristany F, Òdena A, Sánchez-Guixé M, Ibrahim YH, Villacampa G, Grueso J, Parés M, Guzman M, Rodriguez O, Bruna A, Hirst CS, Barnicle A, de Bruin EC, Reddy A, Schiavon G, Arribas J, Mills GB, Caldas C, Dienstman R, Prat A, Nuciforo P, Razavi P, Scaltriti M, Turner NC, Saura C, Davies BR, Oliveira M, Serra V.

Clin Cancer Res. 2020 Mar 27. pii: clincanres.3324.2019. doi: 10.1158/1078-0432.CCR-19-3324. [Epub ahead of print]

PMID:
32220884
3.

Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy Specimens.

Krishnamurthy S, Sabir S, Ban K, Wu Y, Sheth R, Tam A, Meric-Bernstam F, Shaw K, Mills G, Bassett R, Hamilton S, Hicks M, Gupta S.

JAMA Netw Open. 2020 Mar 2;3(3):e200476. doi: 10.1001/jamanetworkopen.2020.0476.

4.

Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.

McGrail DJ, Garnett J, Yin J, Dai H, Shih DJH, Lam TNA, Li Y, Sun C, Li Y, Schmandt R, Wu JY, Hu L, Liang Y, Peng G, Jonasch E, Menter D, Yates MS, Kopetz S, Lu KH, Broaddus R, Mills GB, Sahni N, Lin SY.

Cancer Cell. 2020 Mar 16;37(3):371-386.e12. doi: 10.1016/j.ccell.2020.01.011. Epub 2020 Feb 27.

PMID:
32109374
5.

Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035).

Lee EK, Tan-Wasielewski Z, Aghajanian C, Coleman RL, Curtis J, Hirsch MS, Matulonis UA, Cantley LC, Mills GB, Doyle LA, Liu JF.

Gynecol Oncol Rep. 2020 Feb 3;32:100546. doi: 10.1016/j.gore.2020.100546. eCollection 2020 May.

6.

Immuno-genomic landscape of osteosarcoma.

Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA.

Nat Commun. 2020 Feb 21;11(1):1008. doi: 10.1038/s41467-020-14646-w.

7.

Comprehensive assessment of computational algorithms in predicting cancer driver mutations.

Chen H, Li J, Wang Y, Ng PK, Tsang YH, Shaw KR, Mills GB, Liang H.

Genome Biol. 2020 Feb 20;21(1):43. doi: 10.1186/s13059-020-01954-z.

8.

Using high-frequency phosphorus monitoring for water quality management: a case study of the upper River Itchen, UK.

Fones GR, Bakir A, Gray J, Mattingley L, Measham N, Knight P, Bowes MJ, Greenwood R, Mills GA.

Environ Monit Assess. 2020 Feb 18;192(3):184. doi: 10.1007/s10661-020-8138-0.

9.

Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.

Berg HF, Ju Z, Myrvold M, Fasmer KE, Halle MK, Hoivik EA, Westin SN, Trovik J, Haldorsen IS, Mills GB, Krakstad C, Werner HMJ.

Br J Cancer. 2020 Mar;122(7):1014-1022. doi: 10.1038/s41416-020-0745-6. Epub 2020 Feb 10.

PMID:
32037399
10.

Author Correction: Membrane protein megahertz crystallography at the European XFEL.

Gisriel C, Coe J, Letrun R, Yefanov OM, Luna-Chavez C, Stander NE, Lisova S, Mariani V, Kuhn M, Aplin S, Grant TD, Dörner K, Sato T, Echelmeier A, Villarreal JC, Hunter MS, Wiedorn MO, Knoska J, Mazalova V, Roy-Chowdhury S, Yang JH, Jones A, Bean R, Bielecki J, Kim Y, Mills G, Weinhausen B, Meza JD, Al-Qudami N, Bajt S, Brehm G, Botha S, Boukhelef D, Brockhauser S, Bruce BD, Coleman MA, Danilevski C, Discianno E, Dobson Z, Fangohr H, Martin-Garcia JM, Gevorkov Y, Hauf S, Hosseinizadeh A, Januschek F, Ketawala GK, Kupitz C, Maia L, Manetti M, Messerschmidt M, Michelat T, Mondal J, Ourmazd A, Previtali G, Sarrou I, Schön S, Schwander P, Shelby ML, Silenzi A, Sztuk-Dambietz J, Szuba J, Turcato M, White TA, Wrona K, Xu C, Abdellatif MH, Zook JD, Spence JCH, Chapman HN, Barty A, Kirian RA, Frank M, Ros A, Schmidt M, Fromme R, Mancuso AP, Fromme P, Zatsepin NA.

Nat Commun. 2020 Jan 30;11(1):703. doi: 10.1038/s41467-020-14436-4.

11.

PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis.

Yu K, Lin CJ, Hatcher A, Lozzi B, Kong K, Huang-Hobbs E, Cheng YT, Beechar VB, Zhu W, Zhang Y, Chen F, Mills GB, Mohila CA, Creighton CJ, Noebels JL, Scott KL, Deneen B.

Nature. 2020 Feb;578(7793):166-171. doi: 10.1038/s41586-020-1952-2. Epub 2020 Jan 29.

PMID:
31996845
12.

Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.

Ye Y, Hu Q, Chen H, Liang K, Yuan Y, Xiang Y, Ruan H, Zhang Z, Song A, Zhang H, Liu L, Diao L, Lou Y, Zhou B, Wang L, Zhou S, Gao J, Jonasch E, Lin SH, Xia Y, Lin C, Yang L, Mills GB, Liang H, Han L.

Nat Metab. 2019 Apr;1(4):431-444. doi: 10.1038/s42255-019-0045-8. Epub 2019 Mar 18.

13.

EMR-Based Intervention Improves Cervical Cancer Screening Rate in a Primary Care Office.

Aragón M, Lai S, Deffler J, Woods A, Cymring B, Graham K, Cunningham A, Mills G.

Am J Med Qual. 2020 Jan 24:1062860619900929. doi: 10.1177/1062860619900929. [Epub ahead of print] No abstract available.

PMID:
31973549
14.

Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.

Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S.

Cancer Res. 2020 Jan 15;80(2):362. doi: 10.1158/0008-5472.CAN-19-3573. No abstract available.

15.

Assessing prospective memory in children using the Memory for Intentions Screening Test for Youth (MISTY).

Mills GN, Garbarino JT, Raskin SA.

Clin Neuropsychol. 2020 Jan 14:1-17. doi: 10.1080/13854046.2019.1711198. [Epub ahead of print]

PMID:
31933412
16.

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.

Bollu LR, Shepherd J, Zhao D, Ma Y, Tahaney W, Speers C, Mazumdar A, Mills GB, Brown PH.

NPJ Breast Cancer. 2020 Jan 3;6:2. doi: 10.1038/s41523-019-0143-5. eCollection 2020.

17.

Challenges, gaps and opportunities in investigating the interactions of ozone pollution and plant ecosystems.

Paoletti E, Feng Z, De Marco A, Hoshika Y, Harmens H, Agathokleous E, Domingos M, Mills G, Sicard P, Zhang L, Carrari E.

Sci Total Environ. 2020 Mar 20;709:136188. doi: 10.1016/j.scitotenv.2019.136188. Epub 2019 Dec 19. No abstract available.

PMID:
31887502
18.

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.

Parashar D, Geethadevi A, Aure MR, Mishra J, George J, Chen C, Mishra MK, Tahiri A, Zhao W, Nair B, Lu Y, Mangala LS, Rodriguez-Aguayo C, Lopez-Berestein G, Camara AKS, Liang M, Rader JS, Ramchandran R, You M, Sood AK, Kristensen VN, Mills GB, Pradeep S, Chaluvally-Raghavan P.

Cell Rep. 2019 Dec 24;29(13):4389-4406.e10. doi: 10.1016/j.celrep.2019.11.085.

19.

Myometrial Pseudoaneurysm and Myelosuppression Following Conservative Management of Caesarean Scar Ectopic Pregnancy.

Omand A, Aubrey C, Mills G, Tankel J.

J Obstet Gynaecol Can. 2019 Dec 18. pii: S1701-2163(19)30767-4. doi: 10.1016/j.jogc.2019.08.023. [Epub ahead of print]

PMID:
31864915
20.

Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance.

Labrie M, Fang Y, Kendsersky ND, Li J, Liang H, Westin SN, Mitri Z, Mills GB.

Adv Exp Med Biol. 2019;1188:251-266. doi: 10.1007/978-981-32-9755-5_14. Review.

PMID:
31820393
21.

Calibration and field application of an innovative passive sampler for monitoring groundwater quality.

Pinasseau L, Wiest L, Volatier L, Fones GR, Mills GA, Mermillod-Blondin F, Vulliet E.

Talanta. 2020 Feb 1;208:120307. doi: 10.1016/j.talanta.2019.120307. Epub 2019 Aug 31.

PMID:
31816757
22.

Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers.

Tuna M, Ju Z, Yoshihara K, Amos CI, Tanyi JL, Mills GB.

Br J Cancer. 2020 Feb;122(3):405-412. doi: 10.1038/s41416-019-0654-8. Epub 2019 Nov 29.

PMID:
31780779
23.

Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.

Tuna M, Liu W, Amos CI, Mills GB.

Neoplasia. 2019 Nov;21(11):1102-1109. doi: 10.1016/j.neo.2019.08.008. Epub 2019 Nov 14.

24.

Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.

Myers AP, Konstantinopoulos PA, Barry WT, Luo W, Broaddus RR, Makker V, Drapkin R, Liu J, Doyle A, Horowitz NS, Meric-Bernstam F, Birrer M, Aghajanian C, Coleman RL, Mills GB, Cantley LC, Matulonis UA, Westin SN.

Int J Cancer. 2019 Nov 12. doi: 10.1002/ijc.32783. [Epub ahead of print]

PMID:
31714586
25.

MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.

Sun C, Li X, Guo E, Li N, Zhou B, Lu H, Huang J, Xia M, Shan W, Wang B, Li K, Weng D, Xu X, Gao Q, Wang S, Hu J, Lu Y, Mills GB, Chen G.

Oncogene. 2020 Feb;39(8):1681-1695. doi: 10.1038/s41388-019-1090-1. Epub 2019 Nov 8.

PMID:
31705064
26.

Membrane protein megahertz crystallography at the European XFEL.

Gisriel C, Coe J, Letrun R, Yefanov OM, Luna-Chavez C, Stander NE, Lisova S, Mariani V, Kuhn M, Aplin S, Grant TD, Dörner K, Sato T, Echelmeier A, Cruz Villarreal J, Hunter MS, Wiedorn MO, Knoska J, Mazalova V, Roy-Chowdhury S, Yang JH, Jones A, Bean R, Bielecki J, Kim Y, Mills G, Weinhausen B, Meza JD, Al-Qudami N, Bajt S, Brehm G, Botha S, Boukhelef D, Brockhauser S, Bruce BD, Coleman MA, Danilevski C, Discianno E, Dobson Z, Fangohr H, Martin-Garcia JM, Gevorkov Y, Hauf S, Hosseinizadeh A, Januschek F, Ketawala GK, Kupitz C, Maia L, Manetti M, Messerschmidt M, Michelat T, Mondal J, Ourmazd A, Previtali G, Sarrou I, Schön S, Schwander P, Shelby ML, Silenzi A, Sztuk-Dambietz J, Szuba J, Turcato M, White TA, Wrona K, Xu C, Abdellatif MH, Zook JD, Spence JCH, Chapman HN, Barty A, Kirian RA, Frank M, Ros A, Schmidt M, Fromme R, Mancuso AP, Fromme P, Zatsepin NA.

Nat Commun. 2019 Nov 4;10(1):5021. doi: 10.1038/s41467-019-12955-3. Erratum in: Nat Commun. 2020 Jan 30;11(1):703.

27.

A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.

Xu X, Wang Y, Mojumdar K, Zhou Z, Jeong KJ, Mangala LS, Yu S, Tsang YH, Rodriguez-Aguayo C, Lu Y, Lopez-Berestein G, Sood AK, Mills GB, Liang H.

J Clin Invest. 2019 Dec 2;129(12):5343-5356. doi: 10.1172/JCI123396.

28.

Anaesthetic depth and complications after major surgery: an international, randomised controlled trial.

Short TG, Campbell D, Frampton C, Chan MTV, Myles PS, Corcoran TB, Sessler DI, Mills GH, Cata JP, Painter T, Byrne K, Han R, Chu MHM, McAllister DJ, Leslie K; Australian and New Zealand College of Anaesthetists Clinical Trials Network; Balanced Anaesthesia Study Group.

Lancet. 2019 Nov 23;394(10212):1907-1914. doi: 10.1016/S0140-6736(19)32315-3. Epub 2019 Oct 20.

PMID:
31645286
29.

Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study.

Westin SN, Sill MW, Coleman RL, Waggoner S, Moore KN, Mathews CA, Martin LP, Modesitt SC, Lee S, Ju Z, Mills GB, Schilder RJ, Fracasso PM, Birrer MJ, Aghajanian C.

Gynecol Oncol. 2019 Dec;155(3):420-428. doi: 10.1016/j.ygyno.2019.09.024. Epub 2019 Oct 15.

PMID:
31623857
30.

Fungal and bacterial community dynamics in substrates during the cultivation of morels (Morchella rufobrunnea) indoors.

Longley R, Benucci GMN, Mills G, Bonito G.

FEMS Microbiol Lett. 2019 Sep 1;366(17). pii: fnz215. doi: 10.1093/femsle/fnz215.

PMID:
31603508
31.

Impact of Cold Ischemic Time and Freeze-Thaw Cycles on RNA, DNA and Protein Quality in Colorectal Cancer Tissues Biobanking.

Fan XJ, Huang Y, Wu PH, Yin XK, Yu XH, Fu XH, Feng LL, Wang YL, Yi HJ, Chen ZT, Yin JX, Zhang DL, Feng WX, Bai SM, Kim T, Mills GB, Lu YL, Wan XB, Wang L.

J Cancer. 2019 Aug 27;10(20):4978-4988. doi: 10.7150/jca.29372. eCollection 2019.

32.

Applications for Passive Sampling of Hydrophobic Organic Contaminants in Water-A Review.

Taylor AC, Fones GR, Vrana B, Mills GA.

Crit Rev Anal Chem. 2019 Oct 10:1-35. doi: 10.1080/10408347.2019.1675043. [Epub ahead of print]

PMID:
31597440
33.

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.

Zhang Z, Lee JH, Ruan H, Ye Y, Krakowiak J, Hu Q, Xiang Y, Gong J, Zhou B, Wang L, Lin C, Diao L, Mills GB, Li W, Han L.

Nat Commun. 2019 Oct 8;10(1):4562. doi: 10.1038/s41467-019-12543-5.

34.

Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis.

Al Shaarani M, Shackelford RE, Master SR, Mills GM, AlZubaidi Y, Mamilly A, Wei EX.

Case Rep Hematol. 2019 Sep 2;2019:1586328. doi: 10.1155/2019/1586328. eCollection 2019.

35.

Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.

Dumbrava EI, Brusco L, Daniels M, Wathoo C, Shaw K, Lu K, Zheng X, Strong L, Litton J, Arun B, Eterovic AK, Routbort M, Patel K, Qi Y, Piha-Paul S, Subbiah V, Hong D, Rodon J, Kopetz S, Mendelsohn J, Mills GB, Chen K, Meric-Bernstam F.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00143. Epub 2019 Apr 11.

PMID:
31517177
36.

Proteomics advances for precision therapy in ovarian cancer.

Labrie M, Kendsersky ND, Ma H, Campbell L, Eng J, Chin K, Mills GB.

Expert Rev Proteomics. 2019 Oct;16(10):841-850. doi: 10.1080/14789450.2019.1666004. Epub 2019 Sep 13.

PMID:
31512530
37.

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.

Arango NP, Brusco L, Shaw KRM, Chen K, Eterovic AK, Holla V, Johnson A, Litzenburger B, Khotskaya YB, Sanchez N, Bailey A, Zheng X, Horombe C, Kopetz S, Farhangfar CJ, Routbort M, Broaddus R, Bernstam EV, Mendelsohn J, Mills GB, Meric-Bernstam F.

Oncotarget. 2019 Aug 27;10(50):5254. doi: 10.18632/oncotarget.27176. eCollection 2019 Aug 27.

38.

Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.

Lluch A, González-Angulo AM, Casadevall D, Eterovic AK, Martínez de Dueñas E, Zheng X, Guerrero-Zotano Á, Liu S, Pérez R, Chen K, Chacón JI, Mills GB, Antolín S, Blancas I, López-Serra P, Carrasco E, Caballero R, Prat A, Rojo F, Gonzalez-Perez A, Meric-Bernstam F, Albanell J.

Eur J Cancer. 2019 Oct;120:54-64. doi: 10.1016/j.ejca.2019.07.003. Epub 2019 Sep 4.

PMID:
31491604
39.

First Measurement of the Total Neutron Cross Section on Argon between 100 and 800 MeV.

Bhandari B, Bian J, Bilton K, Callahan C, Chaves J, Chen H, Cline D, Cooper RL, Danielson D, Danielson J, Dokania N, Elliott S, Fernandes S, Gardiner S, Garvey G, Gehman V, Giuliani F, Glavin S, Gold M, Grant C, Guardincerri E, Haines T, Higuera A, Ji JY, Kadel R, Kamp N, Karlin A, Ketchum W, Koerner LW, Lee D, Lee K, Liu Q, Locke S, Louis WC, Manalaysay A, Maricic J, Martin E, Martinez MJ, Martynenko S, Mauger C, McGrew C, Medina J, Medina PJ, Mills A, Mills G, Mirabal-Martinez J, Olivier A, Pantic E, Philipbar B, Pitcher C, Radeka V, Ramsey J, Rielage K, Rosen M, Sanchez AR, Shin J, Sinnis G, Smy M, Sondheim W, Stancu I, Sterbenz C, Sun Y, Svoboda R, Taylor C, Teymourian A, Thorn C, Tull CE, Tzanov M, Van de Water RG, Walker D, Walsh N, Wang H, Wang Y, Yanagisawa C, Yarritu A, Yoo J; CAPTAIN Collaboration.

Phys Rev Lett. 2019 Jul 26;123(4):042502. doi: 10.1103/PhysRevLett.123.042502.

40.

Identification and validation of a prognostic proteomic signature for cervical cancer.

Rader JS, Pan A, Corbin B, Iden M, Lu Y, Vellano CP, Akbani R, Mills GB, Simpson P.

Gynecol Oncol. 2019 Nov;155(2):324-330. doi: 10.1016/j.ygyno.2019.08.021. Epub 2019 Aug 30.

PMID:
31477280
41.

Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines.

Ruan H, Xiang Y, Ko J, Li S, Jing Y, Zhu X, Ye Y, Zhang Z, Mills T, Feng J, Liu CJ, Jing J, Cao J, Zhou B, Wang L, Zhou Y, Lin C, Guo AY, Chen X, Diao L, Li W, Chen Z, He X, Mills GB, Blackburn MR, Han L.

Genome Med. 2019 Aug 26;11(1):55. doi: 10.1186/s13073-019-0663-5.

42.

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

Buj R, Chen CW, Dahl ES, Leon KE, Kuskovsky R, Maglakelidze N, Navaratnarajah M, Zhang G, Doan MT, Jiang H, Zaleski M, Kutzler L, Lacko H, Lu Y, Mills GB, Gowda R, Robertson GP, Warrick JI, Herlyn M, Imamura Y, Kimball SR, DeGraff DJ, Snyder NW, Aird KM.

Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. doi: 10.1016/j.celrep.2019.07.084.

43.

Using a Community Workgroup Approach to Increase Access to Physical Activity in an Underresourced Urban Community.

Schroeder K, Deatrick JA, Klusaritz H, Bowman C, Williams TT, Lee J, Mills G, Privette D, Early D, Aguilar L, Lipman TH.

Health Promot Pract. 2020 Jan;21(1):5-11. doi: 10.1177/1524839919867649. Epub 2019 Aug 18.

PMID:
31423845
44.

Patient experience and challenges in group concept mapping for clinical research.

Mills GD, LaNoue M, Gentsch AT, Doty AMB, Cunningham A, Nord G, Rising KL.

J Patient Rep Outcomes. 2019 Aug 15;3(1):54. doi: 10.1186/s41687-019-0147-9.

46.

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.

Liu ZB, Ezzedine NE, Eterovic AK, Ensor JE, Huang HJ, Albanell J, Choi DS, Lluch A, Liu Y, Rojo F, Wong H, Martínez-Dueñas E, Guerrero-Zotano Á, Shao ZM, Darcourt JG, Mills GB, Dave B, Chang JC.

Breast Cancer Res Treat. 2019 Nov;178(2):251-261. doi: 10.1007/s10549-019-05374-x. Epub 2019 Aug 6.

PMID:
31388936
47.

Measurements of Nonsinglet Moments of the Nucleon Structure Functions and Comparison to Predictions from Lattice QCD for Q^{2}=4  GeV^{2}.

Albayrak I, Mamyan V, Christy ME, Ahmidouch A, Arrington J, Asaturyan A, Bodek A, Bosted P, Bradford R, Brash E, Bruell A, Butuceanu C, Coleman SJ, Commisso M, Connell SH, Dalton MM, Danagoulian S, Daniel A, Day DB, Dhamija S, Dunne J, Dutta D, Ent R, Gaskell D, Gasparian A, Gran R, Horn T, Huang L, Huber GM, Jayalath C, Johnson M, Jones MK, Kalantarians N, Liyanage A, Keppel CE, Kinney E, Li Y, Malace S, Manly S, Markowitz P, Maxwell J, Mbianda NN, McFarland KS, Meziane M, Meziani ZE, Mills GB, Mkrtchyan H, Mkrtchyan A, Mulholland J, Nelson J, Niculescu G, Niculescu I, Pentchev L, Puckett A, Punjabi V, Qattan IA, Reimer PE, Reinhold J, Rodriguez VM, Rondon-Aramayo O, Sakuda M, Sakumoto WK, Segbefia E, Seva T, Sick I, Slifer K, Smith GR, Steinman J, Solvignon P, Tadevosyan V, Tajima S, Tvaskis V, Vulcan WF, Walton T, Wesselmann FR, Wood SA, Ye Z; E06-009 Collaboration.

Phys Rev Lett. 2019 Jul 12;123(2):022501. doi: 10.1103/PhysRevLett.123.022501.

PMID:
31386522
48.

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.

Mazumdar A, Tahaney WM, Reddy Bollu L, Poage G, Hill J, Zhang Y, Mills GB, Brown PH.

NPJ Breast Cancer. 2019 Jul 26;5:22. doi: 10.1038/s41523-019-0118-6. eCollection 2019.

49.

Impact of long-term nitrogen deposition on the response of dune grassland ecosystems to elevated summer ozone.

Hayes F, Lloyd B, Mills G, Jones L, Dore AJ, Carnell E, Vieno M, Dise N, Fenner N.

Environ Pollut. 2019 Oct;253:821-830. doi: 10.1016/j.envpol.2019.07.088. Epub 2019 Jul 18.

PMID:
31344543
50.

Setting Standards: Previewing AAMI's Forthcoming AEMP Standard.

Mills G.

Biomed Instrum Technol. 2019 Jul/Aug;53(4):310-311. doi: 10.2345/0899-8205-53.4.310. No abstract available.

PMID:
31343923

Supplemental Content

Support Center